益生菌在偏头痛治疗中的研究进展
The Role of Probiotics in Migraine Management: A Review of Advances
DOI: 10.12677/acm.2025.15113269, PDF,   
作者: 李 纳*, 谭 戈#:重庆医科大学附属第一医院神经内科,重庆
关键词: 益生菌偏头痛预防肠道微生物组肠–脑轴Probiotics Migraine Prophylaxis Gut Microbiome Gut-Brain Axis
摘要: 偏头痛是一种常见的原发性头痛,主要表现为单侧、搏动性的中重度头痛,反复发作。偏头痛发作时可伴随恶心、呕吐等胃肠道症状,也可与肠易激综合征、胃潴留等胃肠道疾病共病,表明偏头痛可能与胃肠道存在一定的关系。肠道微生物组可能通过肠–脑轴影响偏头痛。益生菌通过改善肠道微生物组对偏头痛表现出预防性疗效。然而,一些研究发现益生菌可以减少偏头痛的发作频率,一些益生菌显示无效。这可能是因为益生菌的种类、剂量和人群不同。本综述不仅总结了益生菌治疗偏头痛可能的机制和益生菌对偏头痛的预防性疗效,还为未来的相关临床试验的标准化提出了一些建议,以期为偏头痛的治疗提供新思路。
Abstract: Migraine is a common primary headache disorder characterized by recurrent, unilateral, pulsating, and moderate-to-severe pain. Attacks may be accompanied by gastrointestinal symptoms such as nausea and vomiting, and migraine often co-ocscur with gastrointestinal disorders like irritable bowel syndrome and gastroparesis, suggesting a potential link between migraine and the gut. The gut microbiome may influence migraine via the gut-brain axis. Probiotics have demonstrated prophylactic effects on migraine by modulating the gut microbiota. However, while some studies indicate that probiotics can reduce the frequency of migraine attacks, others show no significant benefit. These discrepancies may be attributed to variations in probiotic strains, dosages, and patient populations. This review not only summarizes the potential mechanisms of probiotics in migraine treatment and their prophylactic efficacy but also offers recommendations for standardizing future clinical trials, aiming to provide new insights into migraine management.
文章引用:李纳, 谭戈. 益生菌在偏头痛治疗中的研究进展[J]. 临床医学进展, 2025, 15(11): 1672-1682. https://doi.org/10.12677/acm.2025.15113269

参考文献

[1] Steiner, T.J., Stovner, L.J., Jensen, R., Uluduz, D. and Katsarava, Z. (2020) Migraine Remains Second among the World’s Causes of Disability, and First among Young Women: Findings from GBD2019. The Journal of Headache and Pain, 21, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
[2] Ashina, M., Katsarava, Z., Do, T.P., Buse, D.C., Pozo-Rosich, P., Özge, A., et al. (2021) Migraine: Epidemiology and Systems of Care. The Lancet, 397, 1485-1495. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, Z., Kong, X., Yang, C., Li, X., Guo, H. and Wang, Z. (2024) Global, Regional, and National Burden and Trends of Migraine among Youths and Young Adults Aged 15-39 Years from 1990 to 2021: Findings from the Global Burden of Disease Study 2021. The Journal of Headache and Pain, 25, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
[4] Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 38, 1-211.
[5] Ferrari, M.D., Goadsby, P.J., Burstein, R., Kurth, T., Ayata, C., Charles, A., et al. (2022) Migraine. Nature Reviews Disease Primers, 8, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[6] Kim, S.J., Lee, H.J., Lee, S.H., Cho, S., Kim, K.M. and Chu, M.K. (2023) Most Bothersome Symptom in Migraine and Probable Migraine: A Population-Based Study. PLOS ONE, 18, e0289729. [Google Scholar] [CrossRef] [PubMed]
[7] Arzani, M., Jahromi, S.R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., et al. (2020) Gut-Brain Axis and Migraine Headache: A Comprehensive Review. The Journal of Headache and Pain, 21, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[8] Gazerani, P., Papetti, L., Dalkara, T., Cook, C.L., Webster, C. and Bai, J. (2024) The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis. Nutrients, 16, Article 2222. [Google Scholar] [CrossRef] [PubMed]
[9] Mostofsky, E., Mittleman, M.A., Buettner, C., Li, W. and Bertisch, S.M. (2019) Prospective Cohort Study of Caffeinated Beverage Intake as a Potential Trigger of Headaches among Migraineurs. The American Journal of Medicine, 132, 984-991. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, L., Yin, J., Li, J., Sun, H., Liu, Y. and Yang, J. (2023) Association between Dietary Caffeine Intake and Severe Headache or Migraine in US Adults. Scientific Reports, 13, Article No. 10220. [Google Scholar] [CrossRef] [PubMed]
[11] Zduńska, A., Cegielska, J., Zduński, S. and Domitrz, I. (2023) Caffeine for Headaches: Helpful or Harmful? A Brief Review of the Literature. Nutrients, 15, Article 3170. [Google Scholar] [CrossRef] [PubMed]
[12] Ramsden, C.E., Zamora, D., Faurot, K.R., MacIntosh, B., Horowitz, M., Keyes, G.S., et al. (2021) Dietary Alteration of N-3 and N-6 Fatty Acids for Headache Reduction in Adults with Migraine: Randomized Controlled Trial. BMJ, 374, n1448. [Google Scholar] [CrossRef] [PubMed]
[13] Olivito, I., Simona, F., Tarsitano, A., Pagliuso, M., Tarantino, C., De Lorenzo, A., et al. (2024) Mediterranean Ketogenic Diet Accounts for Reduced Pain Frequency and Intensity in Patients with Chronic Migraine: A Pilot Study. Clinical Nutrition, 43, 1781-1787. [Google Scholar] [CrossRef] [PubMed]
[14] Nguyen, K.V. and Schytz, H.W. (2024) The Evidence for Diet as a Treatment in Migraine—A Review. Nutrients, 16, Article 3415. [Google Scholar] [CrossRef] [PubMed]
[15] Ghavami, A., Khorvash, F., Heidari, Z., Khalesi, S. and Askari, G. (2021) Effect of Synbiotic Supplementation on Migraine Characteristics and Inflammatory Biomarkers in Women with Migraine: Results of a Randomized Controlled Trial. Pharmacological Research, 169, Article 105668. [Google Scholar] [CrossRef] [PubMed]
[16] Martami, F., Togha, M., Seifishahpar, M., Ghorbani, Z., Ansari, H., Karimi, T., et al. (2019) The Effects of a Multispecies Probiotic Supplement on Inflammatory Markers and Episodic and Chronic Migraine Characteristics: A Randomized Double-Blind Controlled Trial. Cephalalgia, 39, 841-853. [Google Scholar] [CrossRef] [PubMed]
[17] Levy, D. and Moskowitz, M.A. (2023) Meningeal Mechanisms and the Migraine Connection. Annual Review of Neuroscience, 46, 39-58. [Google Scholar] [CrossRef] [PubMed]
[18] De Logu, F., Nassini, R., Hegron, A., Landini, L., Jensen, D.D., Latorre, R., et al. (2022) Schwann Cell Endosome CGRP Signals Elicit Periorbital Mechanical Allodynia in Mice. Nature Communications, 13, Article No. 646. [Google Scholar] [CrossRef] [PubMed]
[19] Schain, A.J., Melo‐Carrillo, A., Borsook, D., Grutzendler, J., Strassman, A.M. and Burstein, R. (2018) Activation of Pial and Dural Macrophages and Dendritic Cells by Cortical Spreading Depression. Annals of Neurology, 83, 508-521. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, X. and Levy, D. (2008) Modulation of Meningeal Nociceptors Mechanosensitivity by Peripheral Proteinase-Activated Receptor-2: The Role of Mast Cells. Cephalalgia, 28, 276-284. [Google Scholar] [CrossRef] [PubMed]
[21] Schulte, L.H., Mehnert, J. and May, A. (2020) Longitudinal Neuroimaging over 30 Days: Temporal Characteristics of Migraine. Annals of Neurology, 87, 646-651. [Google Scholar] [CrossRef] [PubMed]
[22] Stankewitz, A., Keidel, L., Rehm, M., Irving, S., Kaczmarz, S., Preibisch, C., et al. (2021) Migraine Attacks as a Result of Hypothalamic Loss of Control. NeuroImage: Clinical, 32, Article 102784. [Google Scholar] [CrossRef] [PubMed]
[23] Brennan, K.C., Bates, E.A., Shapiro, R.E., Zyuzin, J., Hallows, W.C., Huang, Y., et al. (2013) Casein Kinase Iδ Mutations in Familial Migraine and Advanced Sleep Phase. Science Translational Medicine, 5, 183ra56. [Google Scholar] [CrossRef] [PubMed]
[24] Colonna, D.M., Meng, W., Deal, D.D., Gowda, M. and Busija, D.W. (1997) Neuronal NO Promotes Cerebral Cortical Hyperemia during Cortical Spreading Depression in Rabbits. American Journal of Physiology-Heart and Circulatory Physiology, 272, H1315-H1322. [Google Scholar] [CrossRef] [PubMed]
[25] Schock, S.C., Munyao, N., Yakubchyk, Y., Sabourin, L.A., Hakim, A.M., Ventureyra, E.C.G., et al. (2007) Cortical Spreading Depression Releases ATP into the Extracellular Space and Purinergic Receptor Activation Contributes to the Induction of Ischemic Tolerance. Brain Research, 1168, 129-138. [Google Scholar] [CrossRef] [PubMed]
[26] Colonna, D.M., Meng, W., Deal, D.D. and Busija, D.W. (1994) Calcitonin Gene-Related Peptide Promotes Cerebrovascular Dilation during Cortical Spreading Depression in Rabbits. American Journal of Physiology-Heart and Circulatory Physiology, 266, H1095-H1102. [Google Scholar] [CrossRef] [PubMed]
[27] Wahl, M., Schilling, L., Parsons, A.A. and Kaumann, A. (1994) Involvement of Calcitonin Gene-Related Peptide (CGRP) and Nitric Oxide (NO) in the Pial Artery Dilatation Elicited by Cortical Spreading Depression. Brain Research, 637, 204-210. [Google Scholar] [CrossRef] [PubMed]
[28] Olesen, J., Burstein, R., Ashina, M. and Tfelt-Hansen, P. (2009) Origin of Pain in Migraine: Evidence for Peripheral Sensitisation. The Lancet Neurology, 8, 679-690. [Google Scholar] [CrossRef] [PubMed]
[29] Silberstein, S.D. (2004) Migraine. The Lancet, 363, 381-391. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Q., Han, X., Wu, H., Zhang, M., Hu, G., Dong, Z., et al. (2019) Dynamic Changes in CGRP, PACAP, and PACAP Receptors in the Trigeminovascular System of a Novel Repetitive Electrical Stimulation Rat Model: Relevant to Migraine. Molecular Pain, 15, 1-15. [Google Scholar] [CrossRef] [PubMed]
[31] Han, X., Ran, Y., Su, M., Liu, Y., Tang, W., Dong, Z., et al. (2017) Chronic Changes in Pituitary Adenylate Cyclase-Activating Polypeptide and Related Receptors in Response to Repeated Chemical Dural Stimulation in Rats. Molecular Pain, 13, 1-10. [Google Scholar] [CrossRef] [PubMed]
[32] Agirman, G. and Hsiao, E.Y. (2021) Snapshot: The Microbiota-Gut-Brain Axis. Cell, 184, 2524-2524.e1. [Google Scholar] [CrossRef] [PubMed]
[33] Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., et al. (2021) The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders. Pharmacological Research, 172, Article 105840. [Google Scholar] [CrossRef] [PubMed]
[34] Mayer, E.A., Tillisch, K. and Gupta, A. (2015) Gut/Brain Axis and the Microbiota. Journal of Clinical Investigation, 125, 926-938. [Google Scholar] [CrossRef] [PubMed]
[35] Wieërs, G., Belkhir, L., Enaud, R., Leclercq, S., Philippart de Foy, J., Dequenne, I., et al. (2020) How Probiotics Affect the Microbiota. Frontiers in Cellular and Infection Microbiology, 9, Article ID: 454. [Google Scholar] [CrossRef] [PubMed]
[36] Mennigen, R. and Bruewer, M. (2009) Effect of Probiotics on Intestinal Barrier Function. Annals of the New York Academy of Sciences, 1165, 183-189. [Google Scholar] [CrossRef] [PubMed]
[37] Ramachandran, R. (2018) Neurogenic Inflammation and Its Role in Migraine. Seminars in Immunopathology, 40, 301-314. [Google Scholar] [CrossRef] [PubMed]
[38] Cavaillon, J.M. (2001) Pro-versus Anti-Inflammatory Cytokines: Myth or Reality. Cellular and Molecular Biology, 47, 695-702.
[39] Tang, Y., Liu, S., Shu, H., Yanagisawa, L. and Tao, F. (2019) Gut Microbiota Dysbiosis Enhances Migraine-Like Pain via TNFα Upregulation. Molecular Neurobiology, 57, 461-468. [Google Scholar] [CrossRef] [PubMed]
[40] Crawford, J., Liu, S. and Tao, F. (2022) Gut Microbiota and Migraine. Neurobiology of Pain, 11, Article 100090. [Google Scholar] [CrossRef] [PubMed]
[41] Hagerty, S.L., Hutchison, K.E., Lowry, C.A. and Bryan, A.D. (2020) An Empirically Derived Method for Measuring Human Gut Microbiome Alpha Diversity: Demonstrated Utility in Predicting Health-Related Outcomes among a Human Clinical Sample. PLOS ONE, 15, e0229204. [Google Scholar] [CrossRef] [PubMed]
[42] Wen, Z., He, M., Peng, C., Rao, Y., Li, J., Li, Z., et al. (2019) Metabolomics and 16S rRNA Gene Sequencing Analyses of Changes in the Intestinal Flora and Biomarkers Induced by Gastrodia-Uncaria Treatment in a Rat Model of Chronic Migraine. Frontiers in Pharmacology, 10, Article No. 1425. [Google Scholar] [CrossRef] [PubMed]
[43] Park, J. and Floch, M.H. (2007) Prebiotics, Probiotics, and Dietary Fiber in Gastrointestinal Disease. Gastroenterology Clinics of North America, 36, 47-63. [Google Scholar] [CrossRef] [PubMed]
[44] Yassin, L.K., Nakhal, M.M., Alderei, A., Almehairbi, A., Mydeen, A.B., Akour, A., et al. (2025) Exploring the Microbiota-Gut-Brain Axis: Impact on Brain Structure and Function. Frontiers in Neuroanatomy, 19, Article 1504065. [Google Scholar] [CrossRef] [PubMed]
[45] Morris, G., Berk, M., Carvalho, A., Caso, J.R., Sanz, Y., Walder, K., et al. (2017) The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Molecular Neurobiology, 54, 4432-4451. [Google Scholar] [CrossRef] [PubMed]
[46] Li, H., Zhou, D., Gan, R., Huang, S., Zhao, C., Shang, A., et al. (2021) Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13, Article 3211. [Google Scholar] [CrossRef] [PubMed]
[47] Bagarolli, R.A., Tobar, N., Oliveira, A.G., Araújo, T.G., Carvalho, B.M., Rocha, G.Z., et al. (2017) Probiotics Modulate Gut Microbiota and Improve Insulin Sensitivity in DIO Mice. The Journal of Nutritional Biochemistry, 50, 16-25. [Google Scholar] [CrossRef] [PubMed]
[48] Everard, A., Matamoros, S., Geurts, L., Delzenne, N.M. and Cani, P.D. (2014) Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice. mBio, 5, e01011-e01014. [Google Scholar] [CrossRef] [PubMed]
[49] Chen, L., Zou, Y.Y., Lu, F.G., Li, F.J. and Lian, G.H. (2013) Efficacy Profiles for Different Concentrations of Lactobacillus acidophilus in Experimental Colitis. World Journal of Gastroenterology, 19, 5347-5356. [Google Scholar] [CrossRef] [PubMed]
[50] de Roos, N.M., van Hemert, S., Rovers, J.M.P., Smits, M.G. and Witteman, B.J.M. (2017) The Effects of a Multispecies Probiotic on Migraine and Markers of Intestinal Permeability-Results of a Randomized Placebo-Controlled Study. European Journal of Clinical Nutrition, 71, 1455-1462. [Google Scholar] [CrossRef] [PubMed]
[51] Tirani, S.A., Khorvash, F., Saneei, P., Moradmand, Z. and Askari, G. (2024) Effects of Probiotic and Vitamin D Co-Supplementation on Clinical Symptoms, Mental Health, and Inflammation in Adult Patients with Migraine Headache: A Randomized, Triple-Blinded, Placebo-Controlled Trial. BMC Medicine, 22, Article No. 457. [Google Scholar] [CrossRef] [PubMed]
[52] Ghavami, A., Khorvash, F., Khalesi, S., Heidari, Z. and Askari, G. (2021) The Effects of Synbiotic Supplementation on Oxidative Stress and Clinical Symptoms in Women with Migraine: A Double‐Blind, Placebo‐Controlled, Randomized Trial. Journal of Functional Foods, 86, Article 104738. [Google Scholar] [CrossRef
[53] Kappéter, Á., Sipos, D., Varga, A., Vigvári, S., Halda-Kiss, B. and Péterfi, Z. (2023) Migraine as a Disease Associated with Dysbiosis and Possible Therapy with Fecal Microbiota Transplantation. Microorganisms, 11, Article 2083. [Google Scholar] [CrossRef] [PubMed]
[54] Newell, C., Bomhof, M.R., Reimer, R.A., Hittel, D.S., Rho, J.M. and Shearer, J. (2016) Ketogenic Diet Modifies the Gut Microbiota in a Murine Model of Autism Spectrum Disorder. Molecular Autism, 7, Article No. 37. [Google Scholar] [CrossRef] [PubMed]
[55] San Mauro Martín, I., López Oliva, S., Garicano Vilar, E., Sánchez Niño, G.M., Penadés, B.F., Terrén Lora, A., et al. (2024) Effects of Gluten on Gut Microbiota in Patients with Gastrointestinal Disorders, Migraine, and Dermatitis. Nutrients, 16, Article 1228. [Google Scholar] [CrossRef] [PubMed]
[56] Fila, M., Pawłowska, E. and Blasiak, J. (2019) Mitochondria in Migraine Pathophysiology—Does Epigenetics Play a Role? Archives of Medical Science, 15, 944-956. [Google Scholar] [CrossRef] [PubMed]
[57] Fila, M., Chojnacki, C., Chojnacki, J. and Blasiak, J. (2021) Nutrients to Improve Mitochondrial Function to Reduce Brain Energy Deficit and Oxidative Stress in Migraine. Nutrients, 13, Article 4433. [Google Scholar] [CrossRef] [PubMed]
[58] Reijnders, D., Goossens, G.H., Hermes, G.D.A., Neis, E.P.J.G., van der Beek, C.M., Most, J., et al. (2016) Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. Cell Metabolism, 24, 63-74. [Google Scholar] [CrossRef] [PubMed]
[59] Stewardson, A.J., Gaïa, N., François, P., Malhotra-Kumar, S., Delémont, C., Martinez de Tejada, B., et al. (2015) Collateral Damage from Oral Ciprofloxacin versus Nitrofurantoin in Outpatients with Urinary Tract Infections: A Culture-Free Analysis of Gut Microbiota. Clinical Microbiology and Infection, 21, 344.e1-344.e11. [Google Scholar] [CrossRef] [PubMed]
[60] Wilton, L.V., Pearce, G.L. and Mann, R.D. (1996) A Comparison of Ciprofloxacin, Norfloxacin, Ofloxacin, Azithromycin and Cefixime Examined by Observational Cohort Studies. British Journal of Clinical Pharmacology, 41, 277-284. [Google Scholar] [CrossRef] [PubMed]
[61] Chen, J., Wang, Q., Wang, A. and Lin, Z. (2019) Structural and Functional Characterization of the Gut Microbiota in Elderly Women with Migraine. Frontiers in Cellular and Infection Microbiology, 9, Article ID: 470. [Google Scholar] [CrossRef] [PubMed]
[62] He, Q., Wang, W., Xiong, Y., Tao, C., Ma, L., Ma, J., et al. (2023) A Causal Effects of Gut Microbiota in the Development of Mi-Graine. The Journal of Headache and Pain, 24, Article 90.
[63] Meng, X., Li, Q., Wang, D., Li, J., Cui, Y., Sun, Z., et al. (2024) Exploring the Role of Gut Microbiota in Migraine Risk: A Two-Sample Mendelian Randomization Study. Scandinavian Journal of Gastroenterology, 59, 411-418. [Google Scholar] [CrossRef] [PubMed]
[64] Liu, J., Liu, H., Li, W. and Huang, S. (2025) Association between Dietary Index for Gut Microbiota and Self-Reported Severe Headache or Migraine in U.S. Adults: A Cross-Sectional Study from Nhanes. Frontiers in Nutrition, 12, Article ID: 1549251. [Google Scholar] [CrossRef] [PubMed]
[65] Xu, R., Yu, X., Zhang, R., Xu, X., Fan, X., Dong, L., et al. (2025) Association between Live Microbe Intake and Severe Headache or Migraine: Evidence from NHANES 1999-2004. Frontiers in Nutrition, 12, Article ID: 1547371. [Google Scholar] [CrossRef] [PubMed]
[66] Gibson, G.R. and Roberfroid, M.B. (1995) Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics. The Journal of Nutrition, 125, 1401-1412. [Google Scholar] [CrossRef] [PubMed]
[67] d’Angelo, M., Cimini, A., Castelli, V., Quintiliani, M., Benedetti, E. and Cifone, M. (2021) The Emerging Role of Probiotics in Neurodegenerative Diseases: New Hope for Parkinson’s Disease? Neural Regeneration Research, 16, 628-634. [Google Scholar] [CrossRef] [PubMed]
[68] Liu, R.T., Walsh, R.F.L. and Sheehan, A.E. (2019) Prebiotics and Probiotics for Depression and Anxiety: A Systematic Review and Meta-Analysis of Controlled Clinical Trials. Neuroscience & Biobehavioral Reviews, 102, 13-23. [Google Scholar] [CrossRef] [PubMed]
[69] Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O.R., et al. (2016) Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer’s Disease: A Randomized, Double-Blind and Controlled Trial. Frontiers in Aging Neuroscience, 8, Article No. 256. [Google Scholar] [CrossRef] [PubMed]
[70] de Roos, N.M., Giezenaar, C.G.T., Rovers, J.M.P., Witteman, B.J.M., Smits, M.G. and van Hemert, S. (2015) The Effects of the Multispecies Probiotic Mixture Ecologic®barrier on Migraine: Results of an Open-Label Pilot Study. Beneficial Microbes, 6, 641-646. [Google Scholar] [CrossRef] [PubMed]
[71] Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., et al. (2018) The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation. Nutrients, 10, Article 988. [Google Scholar] [CrossRef] [PubMed]
[72] Fusco, W., Lorenzo, M.B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., et al. (2023) Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients, 15, Article 2211. [Google Scholar] [CrossRef] [PubMed]
[73] Straube, A., Müller, H., Stiegelbauer, V. and Frauwallner, A. (2018) Migraine Prophylaxis with a Probiotic. Results of an Uncontrolled Observational Study with 1,020 Patients. MMW-Fortschritte der Medizin, 160, 16-21. [Google Scholar] [CrossRef] [PubMed]
[74] Vajdi, M., Khorvash, F. and Askari, G. (2024) A Randomized, Double-Blind, Placebo-Controlled Parallel Trial to Test the Effect of Inulin Supplementation on Migraine Headache Characteristics, Quality of Life and Mental Health Symptoms in Women with Migraine. Food & Function, 15, 10088-10098. [Google Scholar] [CrossRef] [PubMed]
[75] Xie, Y., Zhou, G., Xu, Y., He, B., Wang, Y., Ma, R., et al. (2019) Effects of Diet Based on Igg Elimination Combined with Probiotics on Migraine Plus Irritable Bowel Syndrome. Pain Research and Management, 2019, Article ID: 7890461. [Google Scholar] [CrossRef] [PubMed]
[76] Vetvik, K.G. and MacGregor, E.A. (2017) Sex Differences in the Epidemiology, Clinical Features, and Pathophysiology of Migraine. The Lancet Neurology, 16, 76-87. [Google Scholar] [CrossRef] [PubMed]
[77] Bidabadi, E., Elyasi, M., Hassanzadeh Rad, A. and Kazemnezhad, E. (2023) The Effect of Probiotics on Headaches in Children with Migraine Treated with Sodium Valproate: A Randomized Controlled Clinical Trial. Iranian Journal of Child Neurology, 17, 119-126.
[78] Bazmamoum, H., Keshtkarsohi, B., Mohammadi, Y. and Fayyazi, A. (2024) Efficacy of Probiotics in Prevention of Migraine Attacks in Children: A Randomized Clinical Trial Study. Iranian Journal of Child Neurology, 18, 103-112.